NEWS
BioControl Medical cordially invites you to attend a presentation on:
Device Based Management of Worsening Chronic HF:
Chronic Vagal Stimulation for Heart Failure
By:
Dr. Paul Hauptman Medical Director, BioControl Medical
Time:
Wednesday, October 24, 2007 at 9:50 a.m.
Location:
Transcatheter Cardiovascular Therapeutics Conference
Room 151AB, Washington Convention Center, Washington D.C.
A Panel Discussion will follow the presentation.
Dr. Paul Hauptman, the medical director at BioControl Medical, is a Professor of Internal Medicine at Saint Louis University School of Medicine and director of heart failure in the Division of Cardiology. Formerly at Brigham and Women’s Hospital/Harvard Medical School, Dr. Hauptman has been involved in many international clinical trials, serves on multiple editorial boards and has an extensive research background in outcomes research.
BioControl Medical (www.biocontrol-medical.com) develops and markets advanced implantable devices for the treatment of autonomic disorders, conditions whereby the autonomic nervous system ceases to function properly, resulting in a disruption to the control of involuntary body processes. The devices enable controlled electrical stimulation of various nerves to achieve therapeutic results. BioControl is currently engaged in an international, multi-center study of the CardioFit™ system for the treatment of heart failure.
For more information about TCT: http://tct2007.com/pdf/TCT07-Final-Program.pdf
|
 |
|
|
